BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38509842)

  • 1. JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway.
    Zhang L; Yang YY; Xie L; Zhou Y; Zhong Z; Ding J; Wang ZH; Wang YL; Liu XP; Yu FX; Wu J
    Clin Transl Med; 2024 Mar; 14(3):e1630. PubMed ID: 38509842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
    Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JCAD, a Gene at the 10p11 Coronary Artery Disease Locus, Regulates Hippo Signaling in Endothelial Cells.
    Jones PD; Kaiser MA; Ghaderi Najafabadi M; Koplev S; Zhao Y; Douglas G; Kyriakou T; Andrews S; Rajmohan R; Watkins H; Channon KM; Ye S; Yang X; Björkegren JLM; Samani NJ; Webb TR
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1711-1722. PubMed ID: 29794114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.
    Zhou J; Hu M; He M; Wang X; Sun D; Huang Y; Cheng X; Fu J; Cai J; Ma T; Tian S; Hu Y; Hu F; Liu D; He Y; Yan L; She ZG; Zhang XJ; Ji YX; Liu H; Li H; Yang H; Zhang P
    Hepatology; 2021 Oct; 74(4):2133-2153. PubMed ID: 34133792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
    Liberale L; Puspitasari YM; Ministrini S; Akhmedov A; Kraler S; Bonetti NR; Beer G; Vukolic A; Bongiovanni D; Han J; Kirmes K; Bernlochner I; Pelisek J; Beer JH; Jin ZG; Pedicino D; Liuzzo G; Stellos K; Montecucco F; Crea F; Lüscher TF; Camici GG
    Eur Heart J; 2023 May; 44(20):1818-1833. PubMed ID: 36469488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
    Konishi T; Schuster RM; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
    Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
    Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
    Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
    Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
    Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
    Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
    Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
    Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
    Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
    Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
    [No Abstract]   [Full Text] [Related]  

  • 14. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
    Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
    Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
    Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T
    Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
    Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
    J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.
    Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H
    J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω.
    Ma C; Peng P; Zhou Y; Liu T; Wang L; Lu C
    Mol Med Rep; 2020 Jul; 22(1):483-493. PubMed ID: 32319642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
    Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
    Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.